Genes, Pills and People

Foreword (F. Collins).
 
Preface.
 
PART I: INTRODUCTION: SCIENCE AND SOCIETY.
 
Public Attitudes About Pharmacogenomics (M. Rothstein, et al.).
 
Pharmacogenomics: Pharmacology and Toxicology in the Genomics (H. Mohrenweiser).
 
The Implications of Population Genetics for Pharmacogenomics (C. Hanis).
 
PART II: RESEARCH AND DEVELOPMENT CHALLENGES AND CONSIDERATIONS.
 
Genome Research and Minorities (H. Greely).
 
Drug Development Strategies (P. Manasco & T. Arledge).
 
Drug Development, Regulation, and Genetically Guided Therapy Pharmacogenomics (D. Feigal & S. Gutman).
 
Intellectual Property and Commercial Aspects of Pharmacogenomics (A. Nunnally, et al.).
 
PART III: CLINICAL APPLICATIONS.
 
Integration of Pharmacogenomics into Medical Practice (G. Omenn & A. Motulsky).
 
Clinical Utility Pharmacogenetics and Pharmacogenomics (N. Holtzman).
 
Medical Liability for Pharmacogenomics (L. Palmer).
 
The Challenges of Pharmacogenomics for Pharmacy Education, Practice, and Regulation (D. Brushwood).
 
PART IV: THE SOCIAL DIMENSION.
 
Economic Implications of Pharmacogenomics (C. Reeder & W. Dickson).
 
Pharmacogenomics and the Social Construction of Identity (M. Foster).
 
Pharmacogenomics: Considerations for Communities of Color (L. Nsiah-Jefferson).
 
Constitutional Issues in the Use of Pharmacogenomic Variations Associated with Race (J. Robertson).
 
PART V: EPILOGUE: POLICY PRESCRIPTIONS (M. Rothstein).
 
Pharmacogenomics and Minority Populations: General Population Survey Questionnaire (M. Rothstein).
 
Index.

"The discussion of societal, legal, economic, and governmental issues go well beyond the sphere of pharmogenomics." ( American Journal for Medical Genetics , September 1, 2005)
"...indispensable guide...as timely as it can be...an impressive multidisciplinary analysis...a must read ..." ( Bioethics , Vol 18(4), August 2004)

"... Pharmacogenomics is highly recommended for anyone with an interest in the field.... Given this book s uniqueness...libraries at any institution teaching pharmcogenomics should have a copy of this book." ( Journal of Pharmacy Technology , Sept/Oct 2003)

"...well written, clear, and informative...a restrained sense of excitement...permeates throughout...clearly...a solid contribution to the discourse." ( Nature Biotechnology , May 1, 2003)

"...an excellent summary of aspects of phamacogenomics...a solid reference for those working in the field and a unique textbook for those new to the subject area." ( Clinical Chemistry , Vol. 49, No. 9)

"...addresses the ethical, legal, and social implications of the individualized medicine that pharmacogenomics stands to create..." ( Genetic Engineering News , Vol 23(14), 2003)